Quick Answer
ARTELO BIOSCIENCES, INC. reported Stockholders Equity of -$1.27 million for the year ending 2025.
- ARTELO BIOSCIENCES, INC. showed a decrease of -144.5% in Stockholders Equity from 2024 to 2025.
- This data is from ARTELO BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $294.0 thousand | Q1 2018: $215.2 thousand | Q2 2018: -$91.3 thousand | Q4 2018: -$475.2 thousand | Q1 2019: -$692.2 thousand | Q2 2019: $134.4 thousand | Q4 2019: $4.96 million | Q1 2020: $3.71 million | Q2 2020: $3.23 million | Q4 2020: $9.05 million | Q4 2020: $8.44 million | Q1 2021: $12.86 million | Q1 2021: $13.29 million | Q2 2021: $11.92 million | Q2 2021: $12.84 million | Q3 2021: $11.48 million | Q4 2021: $28.29 million | Q1 2022: $25.78 million | Q2 2022: $23.84 million | Q3 2022: $21.90 million | Q1 2023: $17.64 million | Q2 2023: $16.27 million | Q3 2023: $14.58 million | Q1 2024: $9.54 million | Q2 2024: $7.30 million | Q3 2024: $6.36 million | Q1 2025: $652.0 thousand | Q2 2025: -$1.41 million | Q3 2025: -$633.0 thousand.
- Over the full 13 years of available data (2014 to 2025), ARTELO BIOSCIENCES, INC.'s Stockholders Equity has declined by 8,734.9%.
- Historical annual values: Fiscal year 2025: -$1.27 million | Fiscal year 2024: $2.86 million | Fiscal year 2023: $11.75 million | Fiscal year 2022: $19.40 million | Fiscal year 2021: $27.17 million | Fiscal year 2021: $12.04 million | Fiscal year 2020: $3.88 million | Fiscal year 2019: $5.46 million | Fiscal year 2018: -$135.0 thousand | Fiscal year 2017: $544.8 thousand | Fiscal year 2016: -$13.8 thousand | Fiscal year 2015: $15.9 thousand | Fiscal year 2014: $14.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: